+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biotech Ingredients Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Biotech Ingredients Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Biotech Ingredients Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6010906
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biotech Ingredients Market grew from USD 48.93 billion in 2024 to USD 52.37 billion in 2025. It is expected to continue growing at a CAGR of 6.88%, reaching USD 72.98 billion by 2030.

Global interest in biotech ingredients has never been greater as health, sustainability and innovation converge to redefine multiple industries. Advanced research into carbohydrates, nucleic acids and proteins underpins new product pipelines in agriculture, cosmetics, food & beverages and pharmaceuticals. Simultaneously, breakthroughs in synthetic biology, gene editing and digital biologics are accelerating time-to-market while tightening regulatory scrutiny. Stakeholders must balance supply chain resilience against evolving tariff regimes, ensure compliance with both EMA and FDA frameworks and anticipate shifting consumer preferences toward plant-based, sustainable and personalized solutions. This executive summary distills the most critical developments shaping today’s biotech ingredient ecosystem, offering decision-makers concise analysis on transformative technology trends, trade and policy impacts, segmentation dynamics, regional variations and competitive positioning. By weaving together expert insights and real-world examples, this report empowers industry leaders to make informed strategic decisions, optimize operational models and seize emerging growth opportunities in a rapidly evolving landscape.

Transformative Technology and Market Forces Driving Innovation

Biotech ingredients are undergoing transformative shifts that are redefining value creation across the entire supply chain. First, the rise of synthetic biology platforms-leveraging CRISPR technology, gene editing and metabolic engineering-has enabled the scalable production of high-purity enzymatic proteins and complex polysaccharides with unprecedented precision. Parallel to this, digital biologics tools are streamlining R&D workflows, allowing researchers to model biochemical pathways in silico and accelerate product optimization cycles. At the same time, manufacturers are adopting continuous fermentation processes alongside advanced solvent extraction and supercritical fluid extraction methods to enhance yield, reduce solvent use and minimize environmental impact.

Moreover, consumer demand is pivoting toward health-conscious, vegetarian and vegan formulations, driving companies to innovate functional foods, nutraceuticals and clean-label flavor enhancers. In the cosmetics vertical, sustainability mandates are prompting greater use of bio-based skincare actives and oral care enzymes. Within pharmaceuticals, novel drug delivery platforms are integrating signaling proteins and oligonucleotides into next-generation vaccines and targeted therapies. Finally, strategic alliances between startups, academic research labs and established firms are proliferating, accelerating technology transfer and fostering new joint ventures. Collectively, these trends signal a new era of agility and collaboration, reshaping competitive dynamics and delivering higher-value, differentiated products to market.

Navigating the Impact of 2025 U.S. Tariffs on Supply Chains

The introduction of cumulative United States tariffs in 2025 is exerting tangible pressure on global supply chains and pricing strategies. With increased duties on imported raw material suppliers-particularly those providing enzymatic additives and organic chemicals from key Asia-Pacific hubs-producers are facing higher input costs that ripple across the value chain. In response, many processors and intermediate manufacturers are reevaluating their sourcing strategies, shifting toward domestic fermentation and extraction facilities to hedge against tariff volatility.

These tariffs have also spurred accelerated investment in synthetic biology and gene editing platforms within North America, as companies seek to localize production of high-value nucleic acids and polysaccharides. Regulatory complexity has intensified, requiring closer coordination with both state and federal agencies to secure cost-effective compliance pathways. Meanwhile, global competitors are adapting by forging new distribution partnerships in the Americas and expanding contract manufacturing in tariff-exempt jurisdictions. Consequently, the evolving trade environment is reshaping competitive positioning, incentivizing on-shore capacity expansion and prompting proactive risk management practices across sourcing, manufacturing and logistics.

Comprehensive Segmentation Insights Across the Market

In examining key segmentation insights, ingredient type remains foundational: producers of carbohydrates are refining monosaccharide, oligosaccharide and polysaccharide portfolios to meet tailored functional requirements, while nucleic acid innovators are scaling DNA, oligonucleotide and RNA offerings for diagnostics and therapeutics. Protein developers are differentiating enzymatic proteins, signaling proteins and structural proteins to address specific performance metrics. Application verticals reveal a dynamic spread: biofertilizer and biopesticide developers are transforming agriculture, hair care formulators are integrating novel actives alongside oral care specialists, and flavor enhancer designers are collaborating with functional food and nutraceutical pioneers. Within pharmaceuticals, drug delivery firms are dovetailing with drug synthesis specialists and vaccine developers to accelerate pipeline throughput.

On the production front, extraction houses are optimizing solvent extraction and supercritical fluid extraction techniques, while fermentation teams balance batch and continuous fermentation to maximize productivity. Synthetic biology groups leverage CRISPR, gene editing and metabolic engineering to reduce development cycles. End-user engagement segments highlight dual tracks of academic institutions-spanning research labs and universities-and biotech companies that range from established firms to agile startups. Innovation drivers underscore the interplay of private and public R&D investments, EMA authorizations and FDA approvals alongside cutting-edge digital biologics platforms. The value chain is further dissected between intermediate processors and raw material suppliers of enzymatic additives and organic chemicals. Finally, consumer demographics-including adults, seniors, teens and health-conscious or vegetarian/vegan lifestyles-are shaping product design and go-to-market strategies across every category.

Differentiated Regional Developments Shaping Growth

Regional nuances are critical to global strategy. In the Americas, robust life sciences clusters in the United States and Canada benefit from well-established regulatory frameworks and strong venture capital activity, spurring growth in digital biologics and fermentation capacity. Latin America’s emerging markets are attracting interest in biofertilizers and nutraceuticals, driven by abundant agricultural feedstocks. In Europe, Middle East & Africa, the European Union’s sustainability and bioeconomy initiatives are propelling investment in green extraction methods and value chain circularity, while EMA authorization processes remain pivotal for ingredient approval. The United Kingdom’s post-Brexit regulatory environment continues to evolve, creating both challenges and opportunities for market entry.

Meanwhile, rapidly expanding Asia-Pacific markets-anchored by China, India and Japan-are leveraging large-scale fermentation infrastructures, solvent extraction advancements and synthetic biology hubs. Government funding and public-private partnerships are accelerating R&D in drug synthesis and novel vaccine platforms. Across the Gulf region and North Africa, substantial capital inflows are supporting new manufacturing corridors with a focus on biopesticides and biosafety applications. These regional dynamics underscore the importance of local regulatory engagement, supply chain diversification and strategic investment to capture the full spectrum of growth opportunities.

Competitive Intelligence and Strategic Positioning of Key Players

Competitive landscapes are evolving as leading companies adapt to technology shifts and market demands. Global pharmaceutical giants such as AbbVie Inc., AstraZeneca PLC, Merck & Co., Inc., Novartis AG and Pfizer Inc. continue to allocate significant R&D budgets toward advanced biologics and targeted delivery systems. Specialty biotech firms including Amyris, Inc., Evolva Holding SA and Sollice Biotech are pioneering metabolic engineering and fermentation-based production of rare ingredients. Flavor and fragrance leaders like Givaudan SA, Firmenich SA by Koninklijke DSM N.V. and International Flavors & Fragrances Inc. are integrating enzymatic additives and organic chemical innovations to develop next-generation aroma and taste profiles.

Diagnostic and analytical ingredient providers-such as Becton Dickinson and Company and bioMérieux SA-are expanding assay portfolios with high-precision oligonucleotides. Established biomanufacturers including Boehringer Ingelheim International GmbH, Bloomage Biotechnology Corp., Ltd. and Contipro a.s. are scaling intermediate manufacturing and solvent extraction facilities. Additionally, Hayashibara Co., Ltd. by NAGASE & CO., LTD., Evonik Industries AG and Symrise AG are forming strategic alliances to enhance cosmetic and oral care ingredient lines. Across the value chain, smaller agile players and startups are forging partnerships with academic institutions to accelerate time to approval and diversify product pipelines. This competitive ecosystem highlights the importance of strategic collaborations, targeted investments and technology licensing to maintain leadership.

Actionable Strategies for Industry Leadership

To thrive in this dynamic environment, industry leaders should pursue several targeted actions. First, diversify supply chains by combining domestic fermentation and extraction capabilities with selective imports from tariff-advantaged regions. Second, invest in advanced production technologies-especially CRISPR, gene editing and continuous fermentation-to improve yield, reduce time to market and lower environmental footprints. Third, engage proactively with regulatory agencies to streamline EMA and FDA approvals, leveraging digital biologics data to support safety and efficacy dossiers.

Fourth, form cross-sector alliances between academic research labs, startups and established firms to accelerate technology transfer and share risk. Fifth, integrate sustainability metrics and circular economy principles into value chain design, prioritizing green extraction methods and bio-based raw material sourcing. Sixth, tailor product portfolios to consumer demographics and lifestyle preferences by developing age-specific and health-conscious formulations. Finally, implement real-time data analytics across R&D, manufacturing and market intelligence to anticipate shifts in application verticals and respond quickly to policy changes.

Conclusion: Seizing Opportunities in a Complex Market

The biotechnology ingredients market stands at a pivotal moment, shaped by rapid technological progress, evolving regulatory landscapes and shifting consumer expectations. Organizations that harness synthetic biology, digital biologics and green production methods will establish durable competitive advantages. At the same time, effective navigation of trade policies and strategic partnerships will be essential to mitigate risk and capture fragmented regional opportunities. By aligning R&D investments with clear segmentation insights-from ingredient type and application vertical to end-user engagement and innovation drivers-companies can optimize portfolios and accelerate commercialization. Ultimately, those who act decisively to integrate sustainability, regulatory alignment and supply chain resilience will lead the next wave of growth.

Market Segmentation & Coverage

This research report categorizes the Biotech Ingredients Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Carbohydrates
    • Monosaccharides
    • Oligosaccharides
    • Polysaccharides
  • Nucleic Acids
    • DNA
    • Oligonucleotides
    • RNA
  • Proteins
    • Enzymatic Proteins
    • Signaling Proteins
    • Structural Proteins
  • Agriculture
    • Biofertilizers
    • Biopesticides
    • Biosafety in Crops
  • Cosmetics
    • Hair Care
    • Oral Care
    • Skincare
  • Food & Beverages
    • Flavor Enhancers
    • Functional Foods
    • Nutraceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Drug Synthesis
    • Vaccines
  • Extraction
    • Solvent Extraction
    • Supercritical Fluid Extraction
  • Fermentation
    • Batch Fermentation
    • Continuous Fermentation
  • Synthetic Biology
    • CRISPR Technology
    • Gene Editing
    • Metabolic Engineering
  • Academic Institutions
    • Research Labs
    • Universities
  • Biotech Companies
    • Established Firms
    • Startups
  • R&D Investments
    • Private Investments
    • Public Funding
  • Regulatory Approvals
    • EMA Authorizations
    • FDA Approvals
  • Technological Advancements
    • Digital Biologics
  • Processors
    • Intermediate Manufacturers
  • Raw Material Suppliers
    • Enzymatic Additives
    • Organic Chemicals
  • Age Group
    • Adults
    • Seniors
    • Teens
  • Lifestyle
    • Health-Conscious
    • Vegetarian/Vegan

This research report categorizes the Biotech Ingredients Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Biotech Ingredients Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Advanced Biotech
  • Amyris, Inc.
  • AstraZeneca PLC
  • Becton Dickinson and Company
  • bioMérieux SA
  • Bloomage Biotechnology Corp., Ltd.
  • Boehringer Ingelheim International GmbH
  • Contipro a.s.
  • Eli Lilly and Company
  • Evolva Holding SA
  • Evonik Industries AG
  • Firmenich SA by Koninklijke DSM N.V.
  • Givaudan SA
  • Hayashibara Co., Ltd. by NAGASE & CO., LTD.
  • International Flavors & Fragrances Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sollice Biotech
  • Symrise AG
  • T. HASEGAWA CO., LTD.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biotech Ingredients Market, by Ingredient Type
8.1. Introduction
8.2. Carbohydrates
8.2.1. Monosaccharides
8.2.2. Oligosaccharides
8.2.3. Polysaccharides
8.3. Nucleic Acids
8.3.1. DNA
8.3.2. Oligonucleotides
8.3.3. RNA
8.4. Proteins
8.4.1. Enzymatic Proteins
8.4.2. Signaling Proteins
8.4.3. Structural Proteins
9. Biotech Ingredients Market, by Application Vertical
9.1. Introduction
9.2. Agriculture
9.2.1. Biofertilizers
9.2.2. Biopesticides
9.2.3. Biosafety in Crops
9.3. Cosmetics
9.3.1. Hair Care
9.3.2. Oral Care
9.3.3. Skincare
9.4. Food & Beverages
9.4.1. Flavor Enhancers
9.4.2. Functional Foods
9.4.3. Nutraceuticals
9.5. Pharmaceuticals
9.5.1. Drug Delivery
9.5.2. Drug Synthesis
9.5.3. Vaccines
10. Biotech Ingredients Market, by Production Technology
10.1. Introduction
10.2. Extraction
10.2.1. Solvent Extraction
10.2.2. Supercritical Fluid Extraction
10.3. Fermentation
10.3.1. Batch Fermentation
10.3.2. Continuous Fermentation
10.4. Synthetic Biology
10.4.1. CRISPR Technology
10.4.2. Gene Editing
10.4.3. Metabolic Engineering
11. Biotech Ingredients Market, by End-User Engagement
11.1. Introduction
11.2. Academic Institutions
11.2.1. Research Labs
11.2.2. Universities
11.3. Biotech Companies
11.3.1. Established Firms
11.3.2. Startups
12. Biotech Ingredients Market, by Innovation Drivers
12.1. Introduction
12.2. R&D Investments
12.2.1. Private Investments
12.2.2. Public Funding
12.3. Regulatory Approvals
12.3.1. EMA Authorizations
12.3.2. FDA Approvals
12.4. Technological Advancements
12.4.1. Digital Biologics
13. Biotech Ingredients Market, by Value Chain
13.1. Introduction
13.2. Processors
13.2.1. Intermediate Manufacturers
13.3. Raw Material Suppliers
13.3.1. Enzymatic Additives
13.3.2. Organic Chemicals
14. Biotech Ingredients Market, by Consumer Demographics
14.1. Introduction
14.2. Age Group
14.2.1. Adults
14.2.2. Seniors
14.2.3. Teens
14.3. Lifestyle
14.3.1. Health-Conscious
14.3.2. Vegetarian/Vegan
15. Americas Biotech Ingredients Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Biotech Ingredients Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Biotech Ingredients Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. AbbVie Inc.
18.3.2. Advanced Biotech
18.3.3. Amyris, Inc.
18.3.4. AstraZeneca PLC
18.3.5. Becton Dickinson and Company
18.3.6. bioMérieux SA
18.3.7. Bloomage Biotechnology Corp., Ltd.
18.3.8. Boehringer Ingelheim International GmbH
18.3.9. Contipro a.s.
18.3.10. Eli Lilly and Company
18.3.11. Evolva Holding SA
18.3.12. Evonik Industries AG
18.3.13. Firmenich SA by Koninklijke DSM N.V.
18.3.14. Givaudan SA
18.3.15. Hayashibara Co., Ltd. by NAGASE & CO., LTD.
18.3.16. International Flavors & Fragrances Inc.
18.3.17. Merck & Co., Inc.
18.3.18. Novartis AG
18.3.19. Pfizer Inc.
18.3.20. Sanofi S.A.
18.3.21. Sollice Biotech
18.3.22. Symrise AG
18.3.23. T. HASEGAWA CO., LTD.
18.3.24. Teva Pharmaceutical Industries Ltd.
18.3.25. Viatris Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOTECH INGREDIENTS MARKET MULTI-CURRENCY
FIGURE 2. BIOTECH INGREDIENTS MARKET MULTI-LANGUAGE
FIGURE 3. BIOTECH INGREDIENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. BIOTECH INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. BIOTECH INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOTECH INGREDIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY MONOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY OLIGOSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMATIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SIGNALING PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY STRUCTURAL PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOFERTILIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOPESTICIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOSAFETY IN CROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SKINCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FLAVOR ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY DRUG SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SUPERCRITICAL FLUID EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BATCH FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CONTINUOUS FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY METABOLIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ESTABLISHED FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY STARTUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PRIVATE INVESTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PUBLIC FUNDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY EMA AUTHORIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY FDA APPROVALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY DIGITAL BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY INTERMEDIATE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ENZYMATIC ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ORGANIC CHEMICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY TEENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY HEALTH-CONSCIOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY VEGETARIAN/VEGAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 175. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 177. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 178. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 179. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 180. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 181. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 182. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 183. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 184. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 186. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 187. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 188. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 190. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 191. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 192. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 193. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 194. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 195. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 196. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 197. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 198. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 199. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 200. CANADA BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 212. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 213. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 214. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 223. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 224. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 225. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 226. MEXICO BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES BIOTECH INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC BIOTECH INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 307. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 308. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
TABLE 309. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 310. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 311. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY APPLICATION VERTICAL, 2018-2030 (USD MILLION)
TABLE 312. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY AGRICULTURE, 2018-2030 (USD MILLION)
TABLE 313. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 314. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGES, 2018-2030 (USD MILLION)
TABLE 315. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 316. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY EXTRACTION, 2018-2030 (USD MILLION)
TABLE 318. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY FERMENTATION, 2018-2030 (USD MILLION)
TABLE 319. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY SYNTHETIC BIOLOGY, 2018-2030 (USD MILLION)
TABLE 320. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY END-USER ENGAGEMENT, 2018-2030 (USD MILLION)
TABLE 321. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 322. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
TABLE 323. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY INNOVATION DRIVERS, 2018-2030 (USD MILLION)
TABLE 324. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY R&D INVESTMENTS, 2018-2030 (USD MILLION)
TABLE 325. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY REGULATORY APPROVALS, 2018-2030 (USD MILLION)
TABLE 326. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 327. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY VALUE CHAIN, 2018-2030 (USD MILLION)
TABLE 328. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY PROCESSORS, 2018-2030 (USD MILLION)
TABLE 329. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY RAW MATERIAL SUPPLIERS, 2018-2030 (USD MILLION)
TABLE 330. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 331. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 332. CHINA BIOTECH INGREDIENTS MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 333. INDIA BIOTECH INGREDIENTS MARKET SIZE, BY INGREDIENT TYPE, 2018-2030 (USD MILLION)
TABLE 334. INDIA BIOTECH INGREDIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD M

Companies Mentioned

  • AbbVie Inc.
  • Advanced Biotech
  • Amyris, Inc.
  • AstraZeneca PLC
  • Becton Dickinson and Company
  • bioMérieux SA
  • Bloomage Biotechnology Corp., Ltd.
  • Boehringer Ingelheim International GmbH
  • Contipro a.s.
  • Eli Lilly and Company
  • Evolva Holding SA
  • Evonik Industries AG
  • Firmenich SA by Koninklijke DSM N.V.
  • Givaudan SA
  • Hayashibara Co., Ltd. by NAGASE & CO., LTD.
  • International Flavors & Fragrances Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sollice Biotech
  • Symrise AG
  • T. HASEGAWA CO., LTD.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Biotech Ingredients Market Report by Type, Application, and Region 2024-2032 - Product Image

Biotech Ingredients Market Report by Type, Application, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
2025 Biotech Ingredients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Biotech Ingredients Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 154 Pages
  • Global
From
Biotech Ingredients - Global Strategic Business Report - Product Image

Biotech Ingredients - Global Strategic Business Report

  • Report
  • 94 Pages
  • Global
From
Biotech Ingredient Market Report 2025 - Product Image

Biotech Ingredient Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chlorella Ingredients Market by Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Chlorella Ingredients Market by Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From

About the Biotechnology Ingredient Market

The Biotechnology Ingredient market is a subset of the biotechnology industry that focuses on the production and sale of ingredients used in the manufacture of biotechnology products. These ingredients are typically derived from natural sources, such as plants, animals, and microorganisms, and are used to create products such as pharmaceuticals, medical devices, and food additives. The market is highly competitive, with a wide range of companies offering a variety of products. The market is driven by the increasing demand for biotechnology products, as well as the need for more efficient and cost-effective production methods. Companies in the market are constantly innovating to develop new ingredients and technologies that can improve the quality and efficiency of biotechnology products. Some of the major companies in the Biotechnology Ingredient market include BASF, DowDuPont, Lonza, Merck KGaA, and Novozymes. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.